Bausch & Lomb PureVision
This article was originally published in The Gray Sheet
Executive Summary
Firm will pursue relaunch of extended-wear contact lens sales in Germany following European Patent Office revocation of key patent held by Novartis AG/CIBA Vision Sept. 17. The device debuted in Germany in 1999, but sales ceased in April with a Dusseldorf court's initial infringement ruling. B&L is seeking a stay in both German injunction litigation and Irish patent proceedings. Novartis plans to appeal the decision. In the U.S., a federal appeals court barred B&L from selling the lenses in February after finding the products infringed CIBA Night & Day lens patents (1"The Gray Sheet" Sept. 15, 2003, p. 9)...